Wouters OJ, McKee M, Luyten J (2020) Estimated research and development investment needed to bring a new medicine to market, 2009–2018. JAMA, J Am Med Assoc 323:844–853
Article
Google Scholar
DiMasi JA, Grabowski HG, Hansen RW (2016) Innovation in the pharmaceutical industry: new estimates of R&D costs. J Health Econ 47:20–33
Article
Google Scholar
Dominguez LW, Willis JS (2020) Research and development costs of new drugs. J Am Chem Soc 324:516–516
Google Scholar
Scotti L, Scotti MT (2020) Recent advancement in computer-aided drug design. Curr Pharm Des 26:1635–1636
Article
CAS
Google Scholar
Bhagat RT, Butle SR (2021) Drug repurposing: a review. J Pharm Res Int 33:161–169
Article
Google Scholar
Böhm H-J (1992) LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads. J Comput Aided Mol Des 6:593–606
Article
Google Scholar
Clark DE, Frenkel D, Levy SA, Li J, Murray CW, Robson B, Waszkowycz B, Westhead DR (1995) PRO_LIGAND: An approach to de novo molecular design. 1. Application to the design of organic molecules. J Comput Aided Mol Des 9:13–32
Article
CAS
Google Scholar
Gillet VJ, Newell W, Mata P, Myatt G, Sike S, Zsoldos Z, Johnson AP (1994) SPROUT: recent developments in the de novo design of molecules. J Chem Inf Model 34:207–217
Article
CAS
Google Scholar
Pearlman DA, Murcko MA (1996) CONCERTS: dynamic connection of fragments as an approach to de novo ligand design. J Med Chem 39:1651–1663
Article
CAS
Google Scholar
Langdon SR, Ertl P, Brown N (2010) Bioisosteric replacement and scaffold hopping in lead generation and optimization. Mol Inf 29:366–385
Article
CAS
Google Scholar
Sun H, Tawa G, Wallqvist A (2012) Classification of scaffold-hopping approaches. Drug Discovery Today 17:310–324
Article
CAS
Google Scholar
Schneider G, Lee M-L, Stahl M, Schneider P (2000) De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks. J Comput Aided Mol Des 14:487–494
Article
CAS
Google Scholar
Vinkers HM, de Jonge MR, Daeyaert FF, Heeres J, Koymans LM, van Lenthe JH, Lewi PJ, Timmerman H, Van Aken K, Janssen PA (2003) Synopsis: synthesize and optimize system in silico. J Med Chem 46:2765–2773
Article
CAS
Google Scholar
Hartenfeller M, Zettl H, Walter M, Rupp M, Reisen F, Proschak E, Weggen S, Stark H, Schneider G (2012) DOGS: Reaction-Driven de novo Design of Bioactive Compounds. PLoS Comput Biol 8:e1002380
Article
CAS
Google Scholar
Nishibata Y, Itai A (1991) Automatic creation of drug candidate structures based on receptor structure. Starting point for artificial lead generation. Tetrahedron 47:8985–8990
Article
CAS
Google Scholar
Böhm H-J (1992) LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads. J Comput-Aided Mol Des 6:593–606
Article
Google Scholar
Clark DE, Frenkel D, Levy SA, Li J, Murray CW, Robson B, Waszkowycz B, Westhead DR (1995) PRO_LIGAND: An approach to de novo molecular design .1. Application to the design of organic molecules. J Comput-Aided Mol Des 9:13–32
Article
CAS
Google Scholar
Gillet VJ, Newell W, Mata P, Myatt G, Sike S, Zsoldos Z, Johnson AP (1994) SPROUT: recent developments in the de novo design of molecules. J Chem Inf Comput Sci 34:207–217
Article
CAS
Google Scholar
Agarwal AK, Johnson AP, Fishwick CW (2008) Synthesis of de novo designed small-molecule inhibitors of bacterial RNA polymerase. Tetrahedron 64:10049–10054
Article
CAS
Google Scholar
Ji H, Li H, Martásek P, Roman LJ, Poulos TL, Silverman RB (2009) Discovery of highly potent and selective inhibitors of neuronal nitric oxide synthase by fragment hopping. J Med Chem 52:779–797
Article
CAS
Google Scholar
Ji H, Stanton BZ, Igarashi J, Li H, Martásek P, Roman LJ, Poulos TL, Silverman RB (2008) Minimal pharmacophoric elements and fragment hopping, an approach directed at molecular diversity and isozyme selectivity. Design of selective neuronal nitric oxide synthase inhibitors. J Am Chem Soc 130:3900–3914
Article
CAS
Google Scholar
Sova M, Čadež G, Turk S, Majce V, Polanc S, Batson S, Lloyd AJ, Roper DI, Fishwick CW, Gobec S (2009) Design and synthesis of new hydroxyethylamines as inhibitors of D-alanyl-D-lactate ligase (VanA) and D-alanyl-D-alanine ligase (DdlB). Bioorg Med Chem Lett 19:1376–1379
Article
CAS
Google Scholar
Pierce AC, Rao G, Bemis GW (2004) BREED: Generating novel inhibitors through hybridization of known ligands. Application to CDK2, P38, and HIV protease. J Med Chem 47:2768–2775
Article
CAS
Google Scholar
Schneider G, Lee M-L, Stahl M, Schneider P (2000) De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks. J Comput-Aided Mol Des 14:487–494
Article
CAS
Google Scholar
Kutchukian PS, Shakhnovich EI (2010) De novo design: balancing novelty and confined chemical space. Expert Opin Drug Discov 5:789–812
Article
CAS
Google Scholar
Lewell XQ, Judd DB, Watson SP, Hann MM (1998) Recap retrosynthetic combinatorial analysis procedure: a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry. J Chem Inf Comput Sci 38:511–522
Article
CAS
Google Scholar
Sanchez-Lengeling B, Aspuru-Guzik A (2018) Inverse molecular design using machine learning: Generative models for matter engineering. Science 361:360–365
Article
CAS
Google Scholar
Cheng Y, Gong Y, Liu Y, Song B, Zou Q (2021) Molecular design in drug discovery: a comprehensive review of deep generative models. Briefings Bioinf 22:bbab344
Article
Google Scholar
Gupta A, Mueller AT, Huisman BJH, Fuchs JA, Schneider P, Schneider G (2018) Generative Recurrent Networks for De Novo Drug Design. Mol Inf 37:1700111
Article
Google Scholar
Moret M, Friedrich L, Grisoni F, Merk D, Schneider G (2020) Generative molecular design in low data regimes. Nat Mach Intell 2:171–180
Article
Google Scholar
Segler MHS, Kogej T, Tyrchan C, Waller MP (2018) Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks. ACS Cent Sci 4:120–131
Article
CAS
Google Scholar
Santana MVS, Silva-Jr FP (2021) De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning. BMC Chem 15:8
Article
CAS
Google Scholar
Gomez-Bombarelli R, Wei JN, Duvenaud D, Hernandez-Lobato JM, Sanchez-Lengeling B, Sheberla D, Aguilera-Iparraguirre J, Hirzel TD, Adams RP, Aspuru-Guzik A (2018) Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules. ACS Cent Sci 4:268–276
Article
CAS
Google Scholar
Skalic M, Jiménez J, Sabbadin D, De Fabritiis G (2019) Shape-based generative modeling for de novo drug design. J Chem Inf Model 59:1205–1214
Article
CAS
Google Scholar
Zhavoronkov A, Ivanenkov YA, Aliper A, Veselov MS, Aladinskiy VA, Aladinskaya AV, Terentiev VA, Polykovskiy DA, Kuznetsov MD, Asadulaev A et al (2019) Deep learning enables rapid identification of potent DDR1 kinase inhibitors. Nat Biotechnol 37:1038
Article
CAS
Google Scholar
Kadurin A, Nikolenko S, Khrabrov K, Aliper A, Zhavoronkov A (2017) druGAN: an advanced generative adversarial autoencoder model for de novo generation of new molecules with desired molecular properties in silico. Mol Pharmaceutics 14:3098–3104
Article
CAS
Google Scholar
Guimaraes GL, Sanchez-Lengeling B, Outeiral C, Farias PLC, Aspuru-Guzik A: Objective-Reinforced Generative Adversarial Networks (ORGAN) for Sequence Generation Models. arXiv 2018:1705.10843.
Sanchez-Lengeling B, Outeiral C, Guimaraes GL, Aspuru-Guzik A: Optimizing distributions over molecular space. An Objective-Reinforced Generative Adversarial Network for Inverse-design Chemistry (ORGANIC). chemrxiv 2017:5309668.
Wang J, Hsieh C-Y, Wang M, Wang X, Wu Z, Jiang D, Liao B, Zhang X, Yang B, He Q et al (2021) Multi-constraint molecular generation based on conditional transformer, knowledge distillation and reinforcement learning. Nat Mach Intell 3:914–922
Article
Google Scholar
Skalic M, Sabbadin D, Sattarov B, Sciabola S, De Fabritiis G (2019) From Target to Drug: Generative Modeling for the Multimodal Structure-Based Ligand Design. Mol Pharmaceutics 16:4282–4291
Article
CAS
Google Scholar
Bai Q, Tan S, Xu T, Liu H, Huang J, Yao X (2021) MolAICal: a soft tool for 3D drug design of protein targets by artificial intelligence and classical algorithm. Briefings Bioinf 22:161
Article
Google Scholar
Xu MY, Ran T, Chen HM (2021) De novo molecule design through the molecular generative model conditioned by 3D Information of Protein Binding Sites. J Chem Inf Model 61:3240–3254
Article
CAS
Google Scholar
Li Y, Pei J, Lai L (2021) Structure-based de novo drug design using 3D deep generative models. Chem Sci 12:13664–13675
Article
CAS
Google Scholar
Ragoza M, Masuda T, Koes DR (2022) Generating 3D molecules conditional on receptor binding sites with deep generative models. Chem Sci 13:2701–2713
Article
CAS
Google Scholar
Joshi RP, Gebauer NW, Bontha M, Khazaieli M, James RM, Brown JB, Kumar N (2021) 3D-Scaffold: A Deep Learning Framework to Generate 3D Coordinates of Drug-like Molecules with Desired Scaffolds. J Phys Chem B 125:12166–12176
Article
CAS
Google Scholar
Gebauer NW, Gastegger M, Hessmann SS, Müller K-R, Schütt KT (2022) Inverse design of 3d molecular structures with conditional generative neural networks. Nat Commun 13:1–11
Article
Google Scholar
Gebauer N, Gastegger M, Schütt K: Symmetry-adapted generation of 3d point sets for the targeted discovery of molecules. Advances in Neural Information Processing Systems 2019, 32.
Imrie F, Hadfield TE, Bradley AR, Deane CM (2021) Deep generative design with 3D pharmacophoric constraints. Chem Sci 12:14577–14589
Article
CAS
Google Scholar
Wang M, Hsieh C-Y, Wang J, Wang D, Weng G, Shen C, Yao X, Bing Z, Li H, Cao D et al (2022) RELATION: A Deep Generative Model for Structure-Based De Novo Drug Design. J Med Chem 65:9478–9492
Article
CAS
Google Scholar
Sun B, Feng J, Saenko K: Return of frustratingly easy domain adaptation. In: Proceedings of the AAAI Conference on Artificial Intelligence: 2016.
Tzeng E, Hoffman J, Darrell T, Saenko K: Simultaneous deep transfer across domains and tasks. In: Proceedings of the IEEE international conference on computer vision: 2015. 4068–4076.
Cai C, Wang S, Xu Y, Zhang W, Tang K, Ouyang Q, Lai L, Pei J (2020) Transfer Learning for Drug Discovery. J Med Chem 63:8683–8694
Article
CAS
Google Scholar
Taylor ME, Stone P (2009) Transfer Learning for Reinforcement Learning Domains: A Survey. J Mach Learn Res 10:1633–1685
Google Scholar
Bousmalis K, Trigeorgis G, Silberman N, Krishnan D, Erhan D (2016) Domain separation networks arXiv 1608:06019
Google Scholar
Eberhardt J, Santos-Martins D, Tillack AF, Forli S: AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings. J Chem Inf Model 2021, 61:3891–3898.
Griffiths R-R, Hernandez-Lobato JM (2020) Constrained Bayesian optimization for automatic chemical design using variational autoencoders. Chem Sci 11:577–586
Article
CAS
Google Scholar
Wolber G, Langer T (2005) LigandScout: 3-d pharmacophores derived from protein-bound Ligands and their use as virtual screening filters. J Chem Inf Model 45:160–169
Article
CAS
Google Scholar
Wolber G, Dornhofer AA, Langer T (2006) Efficient overlay of small organic molecules using 3D pharmacophores. J Comput-Aided Mol Des 20:773–788
Article
CAS
Google Scholar
Irwin JJ, Sterling T, Mysinger MM, Bolstad ES, Coleman RG (2012) ZINC: A Free Tool to Discover Chemistry for Biology. J Chem Inf Model 52:1757–1768
Article
CAS
Google Scholar
Sterling T, Irwin JJ (2015) ZINC 15 – Ligand Discovery for Everyone. J Chem Inf Model 55:2324–2337
Article
CAS
Google Scholar
Gilson MK, Liu T, Baitaluk M, Nicola G, Hwang L, Chong J (2016) BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucleic Acids Res 44:D1045–D1053
Article
CAS
Google Scholar
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP (2015) ChEMBL web services: streamlining access to drug discovery data and utilities. Nucleic Acids Res 43:W612–W620
Article
CAS
Google Scholar
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The Protein Data Bank. Nucleic Acids Res 28:235–242
Article
CAS
Google Scholar
Otasek D, Morris JH, Boucas J, Pico AR, Demchak B (2019) Cytoscape Automation: empowering workflow-based network analysis. Genome Biol 20:185
Article
Google Scholar
Saito R, Smoot ME, Ono K, Ruscheinski J, Wang P-L, Lotia S, Pico AR, Bader GD, Ideker T (2012) A travel guide to Cytoscape plugins. Nat Methods 9:1069–1076
Article
CAS
Google Scholar
Su X, Hu L, You Z, Hu P, Wang L, Zhao B: A deep learning method for repurposing antiviral drugs against new viruses via multi-view nonnegative matrix factorization and its application to SARS-CoV-2. Briefings Bioinf 2021, 23:bbab526.
Su X, Hu L, You Z, Hu P, Zhao B: Attention-based Knowledge Graph Representation Learning for Predicting Drug-drug Interactions. Briefings Bioinf 2022, 23:bbac140.
Chen X, Liu M-X, Yan G-Y (2012) Drug-target interaction prediction by random walk on the heterogeneous network. Mol BioSyst 8:1970–1978
Article
CAS
Google Scholar
Zhao T, Hu Y, Valsdottir LR, Zang T, Peng J (2021) Identifying drug-target interactions based on graph convolutional network and deep neural network. Briefings Bioinf 22:2141–2150
Article
CAS
Google Scholar
Steuer CE, Khuri FR, Ramalingam SS (2015) The next generation of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of lung cancer. Cancer 121:E1–E6
Article
CAS
Google Scholar